| 05/29/2026 3:15 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 05/29/2026 3:05 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 3:32 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 04/30/2026 3:34 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 10-K/A | |
| 04/21/2026 6:46 PM | Phoenix Biotech Acquisition (1870404) Issuer Francois Eric (1656125) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/21/2026 6:46 PM | Phoenix Biotech Acquisition (1870404) Issuer Francois Eric (1656125) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 3:59 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 04/15/2026 3:05 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 04/14/2026 3:01 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/14/2026 3:03 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 04/01/2026 3:10 PM | Phoenix Biotech Acquisition (1870404) Filer | Form NT 10-K | |
Get the Latest News and Ratings for PBAXW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Phoenix Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/12/2026 2:38 PM | Phoenix Biotech Acquisition (1870404) Subject Tibbs Isaiah (2116034) Filed by | Form SCHEDULE 13G | |
| 02/04/2026 8:18 AM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 02/04/2026 8:12 AM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/03/2026 4:15 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 3:30 PM | Phoenix Biotech Acquisition (1870404) Issuer KUCHARCHUK ANDREW ALBERT (1654127) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | Byrnes Michael (1619893) Reporting Phoenix Biotech Acquisition (1870404) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | Phoenix Biotech Acquisition (1870404) Issuer Ehrlich Christopher B (1293973) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | ATWOOD BRIAN G (1266567) Reporting Phoenix Biotech Acquisition (1870404) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | Phoenix Biotech Acquisition (1870404) Issuer Patel Shami (1378251) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | Phoenix Biotech Acquisition (1870404) Issuer Pierce Kristen (2039649) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | Phoenix Biotech Acquisition (1870404) Issuer LAPORTE KATHLEEN (1196201) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | Phoenix Biotech Acquisition (1870404) Issuer Rolfe Lindsey (1650504) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/08/2026 3:05 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 01/07/2026 3:37 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/19/2025 4:24 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 12/19/2025 3:49 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/11/2025 11:15 PM | Phoenix Biotech Acquisition (1870404) Filer | Form EFFECT | |
| 12/05/2025 4:12 PM | Phoenix Biotech Acquisition (1870404) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 12/02/2025 4:17 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 12/02/2025 4:18 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 12/02/2025 3:10 PM | Phoenix Biotech Acquisition (1870404) Filer | Form DEFA14A | |
| 12/02/2025 7:30 AM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/28/2025 7:31 AM | Phoenix Biotech Acquisition (1870404) Filer | Form DEF 14A | |
| 11/20/2025 3:05 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 11/20/2025 3:05 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 11/19/2025 3:10 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/17/2025 7:45 AM | Phoenix Biotech Acquisition (1870404) Filer | Form NT 10-Q | |
| 11/14/2025 7:20 PM | Phoenix Biotech Acquisition (1870404) Filer | Form PRE 14A | |
| 10/30/2025 3:01 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 10/30/2025 3:01 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
Why this tiny stock may move before the SpaceX IPO drops (Ad) The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillion in stored capital will be looking for a home when it does.
But the real opportunity isn't the IPO itself. Jovine has identified a small-cap supplier trading near $4 that sits directly in the path of xAI's Colossus infrastructure buildout - and a specific trigger in the S-1 could reprice it overnight. Get the ticker and full briefing before the June roadshow begins |
| 10/23/2025 3:05 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 10/23/2025 3:05 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 10/16/2025 3:17 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/14/2025 8:11 AM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/22/2025 3:10 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/05/2025 4:06 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 09/05/2025 4:07 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 09/05/2025 7:32 AM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/04/2025 4:21 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 09/04/2025 4:23 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 09/04/2025 3:05 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/22/2025 4:26 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 08/22/2025 4:30 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 08/22/2025 3:06 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/17/2025 11:15 PM | Phoenix Biotech Acquisition (1870404) Filer | Form EFFECT | |
| 08/14/2025 8:02 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Phoenix Biotech Acquisition (1870404) Subject | Form SCHEDULE 13G/A | |
| 08/08/2025 7:30 PM | Phoenix Biotech Acquisition (1870404) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 07/29/2025 11:15 PM | Phoenix Biotech Acquisition (1870404) Filer | Form EFFECT | |
| 07/14/2025 4:00 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |
| 07/14/2025 7:00 AM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/08/2025 7:00 AM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/30/2025 4:09 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/25/2025 3:01 PM | Phoenix Biotech Acquisition (1870404) Filer | Form 424B3 | |